Rushika M. Perera

11.5k total citations · 7 hit papers
38 papers, 6.8k citations indexed

About

Rushika M. Perera is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Rushika M. Perera has authored 38 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Cell Biology and 11 papers in Oncology. Recurrent topics in Rushika M. Perera's work include Cellular transport and secretion (11 papers), Autophagy in Disease and Therapy (11 papers) and Calcium signaling and nucleotide metabolism (8 papers). Rushika M. Perera is often cited by papers focused on Cellular transport and secretion (11 papers), Autophagy in Disease and Therapy (11 papers) and Calcium signaling and nucleotide metabolism (8 papers). Rushika M. Perera collaborates with scholars based in United States, Australia and Canada. Rushika M. Perera's co-authors include Roberto Zoncu, Nabeel Bardeesy, Alec C. Kimmelman, Pietro De Camilli, Cristina R. Ferrone, Derek Toomre, Matteo Ligorio, Xiaoxu Wang, Lewis C. Cantley and Costas A. Lyssiotis and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Rushika M. Perera

38 papers receiving 6.7k citations

Hit Papers

Glutamine supports pancreatic cancer growth through a KRA... 2013 2026 2017 2021 2013 2020 2015 2016 2017 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rushika M. Perera United States 31 3.8k 1.7k 1.7k 1.5k 1.4k 38 6.8k
Michael Overholtzer United States 40 3.5k 0.9× 1.1k 0.7× 890 0.5× 2.0k 1.3× 1.3k 0.9× 71 7.0k
Zhenkun Lou United States 53 6.8k 1.8× 2.8k 1.6× 1.4k 0.8× 880 0.6× 1.0k 0.7× 134 9.0k
Diana Whitaker‐Menezes United States 49 6.1k 1.6× 2.0k 1.2× 4.6k 2.7× 1.2k 0.8× 1.3k 0.9× 93 9.4k
Ester M. Hammond United Kingdom 43 4.3k 1.1× 2.0k 1.2× 2.5k 1.4× 884 0.6× 808 0.6× 117 6.9k
Francesco Parlati United States 27 6.0k 1.6× 1.0k 0.6× 922 0.5× 3.9k 2.5× 412 0.3× 52 7.5k
Nicholas Denko United States 44 6.5k 1.7× 1.5k 0.8× 5.0k 2.9× 1.4k 0.9× 1.2k 0.8× 93 10.2k
Seth J. Parker United States 25 3.5k 0.9× 1.1k 0.6× 2.3k 1.3× 445 0.3× 660 0.5× 37 5.3k
Stephanos Pavlides United States 36 4.9k 1.3× 1.7k 1.0× 4.0k 2.3× 1.2k 0.8× 989 0.7× 38 7.3k
Donald S. Kirkpatrick United States 50 7.1k 1.8× 1.7k 1.0× 863 0.5× 1.8k 1.2× 2.0k 1.4× 95 8.8k
Julio A. Aguirre‐Ghiso United States 51 4.7k 1.2× 4.9k 2.8× 3.2k 1.9× 2.0k 1.3× 968 0.7× 98 9.9k

Countries citing papers authored by Rushika M. Perera

Since Specialization
Citations

This map shows the geographic impact of Rushika M. Perera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rushika M. Perera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rushika M. Perera more than expected).

Fields of papers citing papers by Rushika M. Perera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rushika M. Perera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rushika M. Perera. The network helps show where Rushika M. Perera may publish in the future.

Co-authorship network of co-authors of Rushika M. Perera

This figure shows the co-authorship network connecting the top 25 collaborators of Rushika M. Perera. A scholar is included among the top collaborators of Rushika M. Perera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rushika M. Perera. Rushika M. Perera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rademaker, Gilles, David J. Anderson, Zuopeng Zhang, et al.. (2025). Leucine aminopeptidase LyLAP enables lysosomal degradation of membrane proteins. Science. 387(6741). eadq8331–eadq8331. 3 indexed citations
2.
Settembre, Carmine & Rushika M. Perera. (2023). Lysosomes as coordinators of cellular catabolism, metabolic signalling and organ physiology. Nature Reviews Molecular Cell Biology. 25(3). 223–245. 113 indexed citations breakdown →
3.
Shin, Hijai R., Lei Wang, Yusuke Sugasawa, et al.. (2022). Lysosomal GPCR-like protein LYCHOS signals cholesterol sufficiency to mTORC1. Science. 377(6612). 1290–1298. 62 indexed citations
4.
Zoncu, Roberto & Rushika M. Perera. (2022). Built to last: lysosome remodeling and repair in health and disease. Trends in Cell Biology. 32(7). 597–610. 50 indexed citations
5.
Perera, Rushika M.. (2021). Zooming in on the cell biology of disease. Molecular Biology of the Cell. 32(22). ae4–ae4. 1 indexed citations
6.
Gupta, Suprit, Vincent Mercier, Hijai R. Shin, et al.. (2021). Lysosomal retargeting of Myoferlin mitigates membrane stress to enable pancreatic cancer growth. Nature Cell Biology. 23(3). 232–242. 49 indexed citations
7.
Davis, Oliver B., Hijai R. Shin, Chun-Yan Lim, et al.. (2020). NPC1-mTORC1 Signaling Couples Cholesterol Sensing to Organelle Homeostasis and Is a Targetable Pathway in Niemann-Pick Type C. Developmental Cell. 56(3). 260–276.e7. 132 indexed citations
8.
Yamamoto, Keisuke, Anthony Venida, Douglas E. Biancur, et al.. (2020). Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature. 581(7806). 100–105. 844 indexed citations breakdown →
9.
Marsh, Timothy, et al.. (2019). Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer. eLife. 8. 51 indexed citations
10.
Castellano, Brian M., Ashley Thelen, Ofer Moldavski, et al.. (2017). Lysosomal cholesterol activates mTORC1 via an SLC38A9–Niemann-Pick C1 signaling complex. Science. 355(6331). 1306–1311. 394 indexed citations breakdown →
11.
Perera, Rushika M. & Roberto Zoncu. (2016). The Lysosome as a Regulatory Hub. Annual Review of Cell and Developmental Biology. 32(1). 223–253. 446 indexed citations breakdown →
12.
Perera, Rushika M., Svetlana Stoykova, Brandon Nicolay, et al.. (2015). Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism. Nature. 524(7565). 361–365. 615 indexed citations breakdown →
13.
Heilmann, Andreas, Rushika M. Perera, Veronika Ecker, et al.. (2014). CDK4/6 and IGF1 Receptor Inhibitors Synergize to Suppress the Growth of p16INK4A-Deficient Pancreatic Cancers. Cancer Research. 74(14). 3947–3958. 90 indexed citations
14.
Son, Jaekyoung, Costas A. Lyssiotis, Haoqiang Ying, et al.. (2013). Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature. 496(7443). 101–105. 1491 indexed citations breakdown →
15.
Nakatsu, Fubito, Rushika M. Perera, Louise Lucast, et al.. (2010). The inositol 5-phosphatase SHIP2 regulates endocytic clathrin-coated pit dynamics. The Journal of Cell Biology. 190(3). 307–315. 91 indexed citations
16.
Zoncu, Roberto, Rushika M. Perera, Daniel M. Balkin, et al.. (2009). A Phosphoinositide Switch Controls the Maturation and Signaling Properties of APPL Endosomes. Cell. 136(6). 1110–1121. 281 indexed citations
17.
Perera, Rushika M., Roberto Zoncu, Terrance G. Johns, et al.. (2007). Internalization, Intracellular Trafficking, Biodistribution of Monoclonal Antibody 806: A Novel Anti-Epidermal Growth Factor Receptor Antibody. Neoplasia. 9(12). 1099–1110. 64 indexed citations
18.
Perera, Rushika M., Roberto Zoncu, Louise Lucast, Pietro De Camilli, & Derek Toomre. (2006). Two synaptojanin 1 isoforms are recruited to clathrin-coated pits at different stages. Proceedings of the National Academy of Sciences. 103(51). 19332–19337. 129 indexed citations
19.
Perera, Rushika M., Yoshitaka Narita, Frank B. Furnari, et al.. (2005). Treatment of Human Tumor Xenografts with Monoclonal Antibody 806 in Combination with a Prototypical Epidermal Growth Factor Receptor–Specific Antibody Generates Enhanced Antitumor Activity. Clinical Cancer Research. 11(17). 6390–6399. 84 indexed citations
20.
Luwor, Rodney B., Hong‐Jian Zhu, Francesca Walker, et al.. (2004). The tumor-specific de2–7 epidermal growth factor receptor (EGFR) promotes cells survival and heterodimerizes with the wild-type EGFR. Oncogene. 23(36). 6095–6104. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026